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Echocardiography for patients undergoing
extracorporeal cardiopulmonary




Echocardiography is an invaluable tool in the management of patients with extracorporeal cardiopulmonary
resuscitation (ECPR) and subsequent extracorporeal membrane oxygenation (ECMO) support and weaning.
At the very beginning, echocardiography can identify the etiology of cardiac arrest, such as massive pulmonary
embolism and cardiac tamponade. Eliminating these culprits saves life and may avoid the initiation of extracorporeal
cardiopulmonary resuscitation. If the underlying causes are not identified or intrinsic to the heart (e.g., such as those
caused by cardiomyopathy and myocarditis), conventional cardiopulmonary resuscitation (CCPR) will continue to
maintain cardiac output. The quality of CCPR can be monitored, and if cardiac output cannot be maintained, early
institution of extracorporeal cardiopulmonary resuscitation may be reasonable. Cannulation is sometimes challenging
for extracorporeal cardiopulmonary resuscitation patients. Fortunately, with the help of ultrasonography procedures
including localization of vessels, selecting a cannula of appropriate size and confirmation of catheter tip may become
easy under sophisticated hand. Monitoring of cardiac function and complications during extracorporeal membrane
oxygenation support can be done with echocardiography. However, the cardiac parameters should be interpreted
with understanding of hemodynamic configuration of extracorporeal membrane oxygenation. Thrombus and blood
stasis can be identified with ultrasound, which may prompt mechanical and pharmacological interventions. The final
step is extracorporeal membrane oxygenation weaning. A number of studies investigated the accuracy of some
echocardiographic parameters in predicting success rate and demonstrated promising results. Parameters and
threshold for successful weaning include aortic VTI ≥ 10 cm, LVEF > 20–25%, and lateral mitral annulus peak
systolic velocity >6 cm/s. However, the effectiveness of echocardiography in ECPR patients cannot be determined
in observational studies and requires randomized controlled trials in the future. The contents in this review are
well known to echocardiography specialists; thus, it should be used as an educational material for emergency
or intensive care physicians. There is a trend that focused echocardiography is performed by intensivists and
emergency physicians.
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Background
Cardiac arrest is one of the most important causes of
sudden death in general population. The causes of car-
diac arrest include, but are not limited to, ischemic heart
disease, trauma, sepsis, cardiac arrhythmia, acute re-
spiratory insufficiency, hypotension, and stroke. The in-
cidence of cardiac arrest is estimated to be 17–53 per
million population per year [1–4]. Cardiopulmonary re-
suscitation (CPR) is the first-line therapy for these pa-
tients. In out-of-hospital cardiac arrest (OHCA), the
major components of CPR include electronic defibrilla-
tion and chest compression, aiming to restore spontan-
eous circulation [5]. Although prompt and high-quality
CPR is effective in rescuing a portion of cardiac arrest
patients, the mortality of conventional CPR (CCPR) is
unacceptably high and a significant number of patients
require further advanced life support [6]. It has been re-
ported that 44% of in-hospital cardiac arrest patients
had a return of spontaneous circulation, and 17% sur-
vived to hospital discharge. However, if the initial pulse-
less arrhythmia was ventricular fibrillation, 58% patients
had return of spontaneous circulation and 34% survived
to discharge [6]. Extracorporeal cardiopulmonary resus-
citation (ECPR) is considered to be an indispensible mo-
dality for those with refractory cardiac pump failure [7].
Extracorporeal membrane oxygenation is always needed
after extracorporeal cardiopulmonary resuscitation; thus,
we discuss on the use of echocardiography through the
entire course of extracorporeal support. There is evi-
dence supporting that extracorporeal cardiopulmonary
resuscitation tends to be superior to conventional CPR
in improving neurological outcome at 3–6 months in
patients with out-of-hospital cardiac arrest (risk ratio,
4.65; 95% CI, 2–10.81) [8]. The same results have been
replicated in pediatric patients and in-hospital cardiac
arrest [9]. It is recommended that the time for the deci-
sion of extracorporeal membrane oxygenation initiation
and extracorporeal membrane oxygenation team activa-
tion should be shortened, particularly during the CPR of
relatively young patients and in-hospital cardiac arrest
(IHCA) patients [10]. In recent years, there is an increase
in the use of extracorporeal membrane oxygenation for
cardiac support, as well as extracorporeal membrane oxy-
genation for acute respiratory failure [11]. Therefore, the
assessment before initiation of extracorporeal membrane
oxygenation and the monitoring during extracorporeal
membrane oxygenation performance are of critical im-
portance [12]. Echocardiography provides a non-invasive,
radiation-free modality for the assessment of patients
undergoing extracorporeal cardiopulmonary resuscitation.
There is a trend that focused echocardiography is per-
formed by intensivists and emergency physicians. The
concepts of critical care echocardiography indicate that
the examination is performed and interpreted by the non-
echocardiographer physician as an extension of the physi-
cal examination for hemodynamic assessment [13]. The
present article aims to provide a comprehensive review of
updated evidence on the use of echocardiography for as-
sessment of extracorporeal cardiopulmonary resuscitation.
Echocardiography in identification of pulmonary
embolism
Massive pulmonary embolism is a common cause of
cardiac arrest with a reported mortality rate between 20
and 50% [14, 15]. Epidemiological study suggested that
incidence of pulmonary embolism increased from 0.03%
in 1997 to 0.13% in 2008, but its case fatality is decreasing
[16] (Fig. 1). This can be partly explained by increased
Fig. 1 Incidence of pulmonary embolism increased from 0.03% in 1997 to 0.13% in 2008, but the case fatality rates decreased from 25 to 8% over
the years [16]. The figure was reused under the terms of the Creative Commons Attribution License
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awareness of this disease and extensive use of ultrasound
for screening. Although there is no high-level evidence
that echocardiography improves clinical outcome in
cardiac arrest patients caused by pulmonary embolism,
there are many case reports suggesting the potential
role of echocardiography in management of such pa-
tients (Table 1). Focused echocardiography has been
recommended for use to identify pulmonary embolism
(PE), and the diagnostic performance is desirable [17, 18].
It is well known that computed tomography pulmonary
angiography (CTPA) is the gold standard for the diagnosis
of PE. However, the emergency setting of ECPR signifi-
cantly limits the performance of CTPA. Thus, echocardi-
ography can be the first modality in this particular setting.
Typical findings of massive PE include marked dilation of
the right heart and the compromised left ventricle (LV)
(Fig. 2). Embolism can be noted for large portion of the
population. However, in situations with disseminated
microvascular embolism, imaging techniques including
echocardiography and computed tomography angiography
are usually unrevealing. The diagnosis was confirmed with
necropsy [19]. These case series suggested that focused
echocardiography performed by an emergency physician
can be efficient in identifying massive PE, and appropri-
ate interventions can be instituted including thromb-
olysis, extracorporeal mechanical support, and even the
underlying causes of pulmonary embolism [19–26].
However, evidence from the case series is subject to selec-
tion bias and thus the diagnostic utility of echocardiog-
raphy in the condition of extracorporeal cardiopulmonary
resuscitation is not well established. We recommend that
focused echocardiography be performed in experienced
centers.
Beyond the determination of PE, ultrasound monitoring
during CPR is able to track the resolution of PE after
thrombolytic therapy. Ramarapu reported that trans-
esophageal echocardiography (TEE) monitoring during
CPR revealed progressive resolution of the intracardiac,
and after 45 min, complete resolution of thrombus was
noted [27].
Echocardiography in monitoring effectiveness of
CCPR and transition to ECPR
A challenge in performing extracorporeal membrane
oxygenation is the timing of extracorporeal membrane
oxygenation initiation. There is some observational evi-
dence that late initiation of extracorporeal membrane
oxygenation results in poor neurological and mortality
outcomes [28–32]. For example, Chen’s study showed
that patients who had conventional cardiopulmonary re-
suscitation for 45 min or less before extracorporeal car-
diopulmonary resuscitation had higher rate of survival
Table 1 Case reports of extracorporeal cardiopulmonary resuscitation caused by pulmonary embolism









Transthoracic Marked RA dilatation,
a small LV, and abnormal
inter-ventricular septal
wall motion
Chowdhury et al. 2015 [21] 63/male Abdominal
surgery




Swol et al. 2016 [22] 5 cases
(37–53 years)
Trauma and injury Not reported Not reported Transthoracic Thrombus of the inferior
vena cava that extended
to the RV
Northey et al. 2015 [23] 34/female No Not reported Not reported Transthoracic Severe RV dilatation with
global systolic impairment
and failure
Lu et al. 2004 [24] 73/male Fracture surgery Not reported Not reported Transesophageal Severely distended RA
and RV, with a large
embolus in the RA
Tsai et al. 1999 [25] 58/female Uterine cervix
carcinoma
Not reported Not reported Transesophageal Marked RA dilation,
a small RV, and nearly
empty chambers of
the left heart, massive
thromboembolism in
the RA
Ilsaas et al 1998 [26] 43/female Cesarean section Not reported Not reported Not reported RV dilation, compressed LV
and tricuspid insufficiency
Liang et al. 2011 [19] 59/male NSCLC Not reported Not reported Transthoracic Marked RV dilation;
LVEF = 68%
Abbreviations: PE pulmonary embolism, RV right ventricular, RA right atrium, LV left ventricle, NSCLC non-small cell lung cancer, LVEF left ventricular ejection fraction
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to discharge than those who had conventional cardiopul-
monary resuscitation greater than 45 min [32]. The
reason may be that conventional cardiopulmonary re-
suscitation is associated with poor perfusion. There is
evidence that even the best-performed chest compres-
sion during cardiopulmonary resuscitation provides
inadequate cardiac output, ranging from 25 to 40% of
the pre-arrest level [33, 34]. Furthermore, cardiopul-
monary resuscitation with chest compression device
was also associated with a period of “low-flow”. Such
low-flow period may dictate the initiation of extracor-
poreal cardiopulmonary resuscitation [35]. Otherwise,
prolonged inadequate tissue perfusion will result in
poor clinical outcome. Thus, extracorporeal cardiopul-
monary resuscitation that is started too later after
cardiac arrest will be futile. On the other hand, initi-
ation of extracorporeal cardiopulmonary resuscitation
cannot be too early because a substantial number of pa-
tients can have return of spontaneous circulation (ROSC)
after a short time of conventional cardiopulmonary
resuscitation. These patients can have good clinical out-
come, while avoiding catastrophic complications induced
by extracorporeal membrane oxygenation.
Therefore, the key issue in transition from conven-
tional cardiopulmonary resuscitation to extracorporeal
membrane oxygenation is the identification of inadequate
cardiac output. Unfortunately, there is no universal agree-
ment on when to start extracorporeal membrane oxygen-
ation from conventional cardiopulmonary resuscitation.
The French guideline recommends initiation of extracor-
poreal cardiopulmonary resuscitation after 30-min conven-
tional cardiopulmonary resuscitation without spontaneous
circulation, and conventional cardiopulmonary resuscita-
tion within 15 min are considered as the contraindication
for extracorporeal cardiopulmonary resuscitation [36]. Kim
and colleagues found that good neurological outcome
appeared to decrease more sharply in the conventional
cardiopulmonary resuscitation than in the extracorporeal
cardiopulmonary resuscitation group with prolongation of
conventional cardiopulmonary resuscitation duration [37].
The survival rate also showed a similar trend (Fig. 3). There
are also other modalities to indicate when to transition to
extracorporeal cardiopulmonary resuscitation. For example,
end-tidal CO2 < 10 mmHg after 20 min of CCPR is a good
predictor of poor clinical outcome and thus may have
potential role in deciding extracorporeal cardiopulmonary
resuscitation initiation [38–40]. Other biomarkers include
serum lactate, creatinine, phosphorous, pH value, and
neuron-specific enolase [41–44]. Echocardiography may
provide an alternative to monitor cardiac output during
CCPR. Cardiac low-flow can be visualized using echocardi-
ography [35]. Despite lack of evidence to support the use of
echocardiography as a method to determine initiation of
extracorporeal cardiopulmonary resuscitation, it is rational
that if adequate cardiac output cannot be maintained
with CCPR, extracorporeal cardiopulmonary resuscita-
tion should be started as early as possible to avoid fur-
ther neurological damage.
An interesting sign of echocardiography during car-
diopulmonary resuscitation is the duration of cardiac
standstill, which was defined as “the total duration of
consecutive absence of cardiac motion when peri-
resuscitation echocardiography was performed serially
every 2 minutes” [45]. Kim et al.’s study found that
patients with and without ROSC had significantly
different standstill duration (2.86 ± 2.07 min versus
20.30 ± 8.42 min, p < 0.001). Cardiac standstill >10 min
was able to predict non-ROSC with 90% sensitivity and
100% specificity. Such a high diagnostic accuracy may
help to triage patients into those who require extracor-
poreal cardiopulmonary resuscitation and those who do
not. We propose that if cardiac standstill is persistent for
one or two CPR cycle, ROSC is very unlikely within an ex-
pected time period and extracorporeal cardiopulmonary
Fig. 2 Morphological changes of the heart in massive pulmonary
embolism (PE). Note the dilated right heart and decompressed
left heart. PE occludes the main trunk of the pulmonary artery,
resulting in marked increase in afterload of the right ventricle.
Abbreviations: SVC superior vena cava, IVC inferior vena cava, RA right
atrium, RV right ventricle, LA left atrium, LV left ventricle, AO aorta,
PA pulmonary artery
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resuscitation can be instituted, given that the underlying
causes of the cardiac arrest is fully reversible.
The risk of performing echocardiography is the interrup-
tion of chest compression, and it is important not to inter-
vene CPR. There have been extensive studies being
conducted to explore the performance of echocardiog-
raphy during CPR [46–48]. The subxiphoid window is the
most commonly used because it will not intervene with
the ongoing CPR (e.g., the placement of ultrasound probe
is outside of the compression region). From this view, it is
easy to observe ventricular wall motion, pericardial effu-
sion, and tamponade [49].
Ultrasonography for ECMO cannulation
Although the primary focus of the article is on echocar-
diography, here, we include ultrasonography for extra-
corporeal membrane oxygenation cannulation. For most
instances, the cannulation can be performed without the
help of ultrasound. However, ultrasound can help to
reduce the rate of complications associated with cannu-
lation such as hematoma, vascular injury, cardiac tam-
ponade, and lower leg ischemia [50, 51]. In pediatric
patients, the use of ultrasound was associated with sig-
nificantly reduced rate of surgical repositioning of extra-
corporeal membrane oxygenation catheter [52].
Before cannulation, the diameter of the target vessels
should be localized and measured with ultrasound. Some
authors suggest that the diameter of the cannula should
be less than two thirds of the diameter of the vessel [50].
Others suggest to choose a cannula that is at least 1–3F
sizes smaller than the vessel. The size of the cannula can
be calculated as follows:
Size Fð Þ ¼ D mmð Þ  3
where D is the diameter of the vessel. If the vessel is dis-
torted by adjacent tissue, the size can be calculated by:
Size Fð Þ ¼ C mmð Þ
where C is the circumference of the distorted vessel.
These two equations are very simple for clinical use [53].
The size of the cannula is particularly important for
femoral artery because occlusion of it may cause lower
extremity ischemia that requires amputation. The can-
nulation can be performed under real-time ultrasound
guidance [54]. The tip position can also be identified by
ultrasound, and there is evidence suggesting its superior-
ity to chest radiography [55]. In VA-extracorporeal
membrane oxygenation, the tip position of the cannula
inserted in the femoral vein is important for reaching a
target flow rate. Optimally, the cannula tip should be po-
sitioned at proximal inferior vena cava, above the hep-
atic vein [56] (Fig. 4). After successful cannulation, the
heart should be scanned with ultrasound to exclude rare
but catastrophic complication tamponade. Furthermore,
the distal limb perfusion should be monitored with
color-Doplar ultrasound. Percutaneous distal limb perfu-
sion should be instituted in the presence of ischemic
signs (Fig. 5) [54].
Fig. 3 Twenty-four-hour survival, good neurological outcome, and survival rate at 3 months appeared to decrease more sharply in the CCPR than
in the extracorporeal cardiopulmonary resuscitation group with prolongation of CPR duration [37]. The figure was reused under the terms of the
Creative Commons Attribution License
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Monitoring during ECMO performance
Cardiac function is one of the most important parameters
that should be closely monitored during extracorporeal
membrane oxygenation support after extracorporeal
cardiopulmonary resuscitation. Echocardiography is a
useful tool in this regard. Systolic function is assessed
with conventional parameters such as the size of the
left ventricle (LV), ejection fraction (EF), mitral regur-
gitation dP/dt, aortic velocity-time integral (VTI). The
extracorporeal membrane oxygenation blood flow rate
can be adjusted according to the global assessment of
LV systolic function and cardiac preload. Aissaoui and
colleagues have systematically investigated the effect
of extracorporeal membrane oxygenation flow rate on
changes in cardiac parameters [57]. A drop in the
extracorporeal membrane oxygenation flow rate from
4 to 0.7 L/min leads to a 22% increase in E/Ea ratio
(5.9 to 7.2; p < 0.001), 17% increase in EF (15 to
17.5%; p < 0.001), 12 and 45% increase in VTI (8 to
11.6 cm; p < 0.001), and 12% increase in left ventricu-
lar end-diastolic volume (95 to 108 mL; p < 0.001).
Another major issue in using echocardiography is to
detect complications during extracorporeal membrane
oxygenation running. As described previously, cardiac
tamponade can happen when a passage of guide wire or
cannula through myocardium. This complication is de-
scribed in this section because anticoagulation during
extracorporeal membrane oxygenation support may
worsen pericardial effusion, and tamponade occurs
hours or days after cannulation. Therefore, it requires
continuous monitoring with echocardiography. What is
worse is that conventional signs and symptoms of car-
diac tamponade may be of limited use during extracor-
poreal membrane oxygenation running [58]. Fortunately,
these complications can be readily detected using echo-
cardiography [59].
Fig. 4 a Appearance of the access cannula. b Position of the access
cannula was localized in proximal inferior vena cava, above the level
of hepatic vein [56]. The figure was reused under the terms of the
Creative Commons Attribution License
Fig. 5 Schematic illustration of distal limb perfusion to prevent
ischemia. A artery, V vein, DPC distal perfusion catheter
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Thrombosis is a major complication during extracor-
poreal membrane oxygenation support and can be cata-
strophic when embolism occurs in the brain. Many
factors predispose the patient at increased risk of blood
clotting. The passage of blood through extracorporeal
circuit activates clotting cascade, which is compounded
by obstruction of intravascular blood flow by the can-
nula. While evident thrombus is detectable with ultra-
sound, blood stasis is somewhat challenging to identify.
The “spontaneous echo contrast” within cardiac cham-
ber is a sign of blood stasis, which is considered as a
harbinger of ensuing thrombosis [60–63]. Closed aortic
valve and absence of pulsatile blood flow, which can be
easily visualized with echocardiography, are also predic-
tors of thrombosis [64–66]. On seeing this sign, some
mechanical or pharmacological efforts could be make to
promote forward blood flow. For example, reducing vas-
cular resistance and extracorporeal membrane oxygen-
ation flow rate may allow aortic valve opening and
increase forward blood flow. Others recommend the use
of intra-aortic balloon pump to facilitate blood flow
[67–69]. Alternatively, the anticoagulation strategy can
be strengthened.
Aortic and mitral regurgitation is a sign of increased
in afterload produced by extracorporeal membrane oxy-
genation support. Theoretically, the increases in after-
load may impair LV distention, ensuing subendocardial
ischemia. These are risk factors for delayed recovery of
cardiac function [70–72]. However, their clinical utility
has been well established in extracorporeal membrane
oxygenation setting, and further studies are warranted to
clarify their association.
Weaning from ECMO
The ultimate goal of extracorporeal membrane oxygen-
ation management is to wean from it. Therefore, the
prediction of successful weaning has long been an area
of active research. Echocardiographic parameters have
been shown to be good predictors of extracorporeal
membrane oxygenation weaning [73]. If a patient is
deemed suitable for weaning, extracorporeal membrane
oxygenation weaning trial can be performed by reducing
extracorporeal membrane oxygenation flow to less than
1.5 L/min. Parameters and threshold for successful
weaning include aortic VTI ≥ 10 cm, LVEF > 20–25%,
and lateral mitral annulus peak systolic velocity >6 cm/s
[56, 74, 75]. By applying a standardized weaning proto-
col [76], Cavarocchi and coworkers developed an extra-
corporeal membrane oxygenation weaning protocol
guided by echocardiography. The ability of ultrasound to
detect left and right ventricular dysfunction was good,
with a sensitivity of 100% (95% CI, 73.2–100%), specifi-
city of 100% (95% CI, 56.1–100%), and positive predict-
ive value of 100% (95% CI, 73–100%) [76]. In pediatric
patients undergoing VA-extracorporeal membrane oxy-
genation for cardiac support, a significant increase
(0.0250 ± 0.269 m; p = 0.03) in VTI when extracorporeal
membrane oxygenation flow rate was dropped from full
support to minimal flow rate was an important predictor
of those not requiring a heart transplant [77]. On the
contrary, children without significant increase (0.0111 ±
0.283 m) in VTI during weaning trial were subjects that
cannot be successfully weaned from extracorporeal
membrane oxygenation.
Conclusions
Echocardiography is an invaluable tool in the management
of patients undergoing extracorporeal cardiopulmonary re-
suscitation and subsequent extracorporeal membrane oxy-
genation support and weaning. At the very beginning,
echocardiography can identify the etiology of cardiac arrest,
such as massive PE and cardiac tamponade. Eliminating
these culprits saves life and may avoid the initiation of
extracorporeal membrane oxygenation. If the underlying
causes are not identified or intrinsic to the heart (e.g., such
as those caused by cardiomyopathy, myocarditis), CCPR
will continue to maintain cardiac output. The quality of
CCPR can be monitored and if cardiac output cannot be
maintained, early institution of extracorporeal cardiopul-
monary resuscitation may be reasonable. Cannulation is
sometimes challenging for extracorporeal cardiopulmonary
resuscitation patients. Fortunately, with the help of ultra-
sonography procedures including localization of vessels,
selecting a cannula of appropriate size, confirmation of
catheter tip may become easy under sophisticated hand.
Monitoring of cardiac function and complications during
extracorporeal membrane oxygenation support can be done
with echocardiography. However, the cardiac parameters
should be interpreted with understanding of hemodynamic
configuration of extracorporeal membrane oxygenation.
Thrombus and blood stasis can be identified with ultra-
sound, which may prompt mechanical and pharmacological
interventions. The final step is extracorporeal membrane
oxygenation weaning. Some studies have investigated the
accuracy of some echocardiographic parameters in pre-
dicting success rate. Although they showed promising
results, the effectiveness of echocardiography on CPR
survival cannot be determined. Further randomized con-
trolled trials comparing the effects of echocardiography-
guided CPR versus conventional CPR may be warranted.
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